中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
27期
29-30,31
,共3页
2型糖尿病%复方苦荞麦方%胰岛素抵抗
2型糖尿病%複方苦蕎麥方%胰島素牴抗
2형당뇨병%복방고교맥방%이도소저항
Type 2 diabetes%FFKQM%Insulin resistance
目的：研究复方苦荞麦方对2型糖尿病大鼠的治疗作用。方法观察各组动物血清中血糖、肿瘤坏死因子-α（TNF-α）、纤溶酶原激活物抑制剂（PAI-1）的含量变化。结果复方苦荞麦方高、低剂量组治疗后血糖、TNF-α、PAI-1下降，其中TNF-α、PAI-1两项指标优于优降糖组。结论复方苦荞麦方具有降低血糖和改善胰岛素抵抗的作用。
目的：研究複方苦蕎麥方對2型糖尿病大鼠的治療作用。方法觀察各組動物血清中血糖、腫瘤壞死因子-α（TNF-α）、纖溶酶原激活物抑製劑（PAI-1）的含量變化。結果複方苦蕎麥方高、低劑量組治療後血糖、TNF-α、PAI-1下降，其中TNF-α、PAI-1兩項指標優于優降糖組。結論複方苦蕎麥方具有降低血糖和改善胰島素牴抗的作用。
목적：연구복방고교맥방대2형당뇨병대서적치료작용。방법관찰각조동물혈청중혈당、종류배사인자-α（TNF-α）、섬용매원격활물억제제（PAI-1）적함량변화。결과복방고교맥방고、저제량조치료후혈당、TNF-α、PAI-1하강，기중TNF-α、PAI-1량항지표우우우강당조。결론복방고교맥방구유강저혈당화개선이도소저항적작용。
Objective To study therapeutic effects of Fufangkuqiaomai(FFKQM)on type2 diabetic rats. Methods Observed the changes of blood glucose, tumor necrosis factor-α(TNF-α), plasminogen activator inhibitor(PAI-1)in serum between each group. Results The levels of blood glucose, TNF-α, PAI-1 decreased after treating FFKQM both in high-dose group and low-dose group, and the indexes of TNF-α,PAI-1 were superior to the glybenzcyclamide group. Conclusion There are protective effects of reducing the blood glucose and improving insulin resistance for FFKQM.
